The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis
Dennis Kobelt(German Cancer Research Center), Ulrike Stein(German Cancer Research Center)
Cited by 14
Related Papers
Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer
|JNCI Journal of the National Cancer Institute|2011|211